Does dexona tablet cause anxiety after stopping it since 3 years?
Answers from top 10 papers
More filters
| Papers (10) | Insight |
|---|---|
| After chronic use, abruptly stopping adrenergic receptor drugs can cause rebound anxiety, restlessness, and heart palpitations. | |
82 Citations | Our findings tend to indicate that, even after long-term treatment, zolpidem does not induce rebound insomnia or daytime anxiety. |
55 Citations | HighlightsDopamine transporter knockout leads to anxiety‐like phenotype in zebrafish. Similar anxiety‐like state found after cocaine exposure and in normal aging. Inhibition of D1 receptor, but not D2/3 receptor, rescued anxiety‐like phenotype. Provides new evidence for role of dopaminergic system in anxiety |
| Dexmedetomidine does not change the overall incidence of agitation after free flap surgery; however, it does decrease agitation after PACU admission. | |
140 Citations | Anxiety remains stable over 3 years poststroke and is best explained by prior, early, anxiety, and female gender. |
13 Citations | This study demonstrates the tendency of anxiety to remain or reappear years after originally identified, with 55% of patients reporting symptoms after 7 years. |
64 Citations | Paroxetine CR effectively treated the symptoms associated with social anxiety disorder and was well tolerated, with few patients stopping treatment due to adverse events. |
17 Citations | Thus while sodium restriction is anxiogenic, it does not exacerbate preexisting depression or anxiety in clearly demarcated behavioral models. |
34 Citations | Steroid replacement therapy may be desirable at a time of stress in the immediate posttreatment period, but it would seem unnecessary 1 month after stopping dexamethasone treatment. |
3 Citations | Even though some of these symptoms can seem similar to a recurrence of the anxiety or insomnia disorder being previously treated, symptoms due to withdrawal tend to have a more immediate onset (8–24 hours after stopping the drug), and usually resolve with time. |
Related Questions
What are the current scientific evidences supporting the use of cannabinoids in the treatment of anxiety disorders?4 answersCurrent scientific evidence regarding the use of cannabinoids in the treatment of anxiety disorders is still preliminary and lacks robust, blinded, and placebo-controlled clinical trials. Although many patients with anxiety disorders report using cannabis to treat their symptoms, the current research does not provide strong evidence to support this. However, a study evaluating quality-of-life outcomes after treatment with various cannabis formulations found that formulations of cannabis significantly improved anxiety, depression, fatigue, and the ability to participate in social activities in participants with anxiety disorders. Another study found positive results for treating Cannabis Use Disorder with CBD and THC, while contradictory and inconclusive results were found for Opioid Use Disorder and Cocaine Use Disorder, respectively. Overall, while there is some evidence suggesting the potential therapeutic use of cannabinoids in anxiety disorders, more research, including robust clinical trials, is needed to establish their efficacy and safety.
How does nicotine increase anxiety?4 answersNicotine increases anxiety by acting on specific circuits in the brain. It was found that nicotine activates dopamine (DA) neurons in the ventral tegmental area (VTA) that project to the nucleus accumbens (NAc), while simultaneously inhibiting DA neurons that project to the amygdala nuclei (Amg). This dual effect of nicotine on different populations of VTA DA neurons may contribute to the anxiogenic effects of nicotine. Nicotine also modulates the transmission of various neurochemicals, including dopamine, γ-amino-butyric acid (GABA), and glutamate, within mesocorticolimbic structures such as the VTA, NAc, and prefrontal cortex (PFC). Animal studies have shown that nicotine withdrawal leads to an increase in anxiety-like behavior, and nicotine-induced changes in corticotropin-releasing factor (CRF) transmission play a role in nicotine withdrawal-related anxiety. Chronic neonatal nicotine exposure can alter neuronal activation in brain areas associated with anxiety, such as the paraventricular hypothalamic nucleus, central nucleus of the amygdala (CeA), and locus coeruleus (LC), leading to increased responsiveness to stress and anxiety later in life. Adolescent nicotine exposure can also cause long-lasting changes in the neural pathways that mediate anxiety, particularly in the Bed Nucleus of the Stria Terminalis (BNST).
Do Cannabinoid systemaffect anxiety?2 answersThe cannabinoid system has been found to affect anxiety. Studies have shown that the cannabinoid system is involved in anxiety, and the administration of cannabinoid receptor agonists and antagonists can lead to conflicting findings in terms of anxiety levels. However, genetic manipulations and the modulation of endocannabinoid availability have shown more consistent effects on anxiety. Additionally, the non-psychotropic phytocannabinoid cannabidiol and the endocannabinoid anandamide have been found to have acute anxiolytic effects and regulate learned fear. The combination of exogenous cannabinoids and diazepam, a GABAergic system modulator, has been shown to produce additive or synergistic effects on anxiety. Overall, the cannabinoid system plays a role in modulating anxiety, and further research is needed to fully understand its mechanisms and potential therapeutic implications.
Do Cannabinoids system affect anxiety?3 answersCannabinoids have been shown to have an effect on anxiety. The endocannabinoid system (ECS) plays a role in regulating anxiety states, and disruption of the ECS can lead to the generation of an anxiety state. On the other hand, upregulation of ECS signaling can alleviate anxiety-like behaviors. Cannabinoid administration has a biphasic effect on anxiety, with low doses being anxiolytic and high doses being anxiogenic. Recent evidence suggests that cannabinoids, particularly cannabidiol, have anxiolytic properties. However, the therapeutic use of cannabinoids for anxiety disorders is still weak and lacking well-designed randomized controlled trials. Further research is needed to fully understand the effects of cannabinoids on anxiety and to determine their potential as a treatment for anxiety disorders.
Can you experience withdrawal after one use?2 answers
What happens when you stop taking osteoporosis medication?7 answers